ProPhase Labs, Inc.
PRPH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000868278
No open-market purchases or sales by ProPhase Labs, Inc. insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $2 in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding ProPhase Labs, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 39 | 45 | +6 |
| Shares | 2.44M | 2.18M | −267.5K (−10.9%) |
| Value | $18.6M | $15.8M | −$2.81M (−15.1%) |
New holders (11)
Institutions that held ProPhase Labs, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Price T Rowe Associates Inc | 17,300 | $126.0K | 0.00% |
| Winton Group Ltd | 16,759 | $121.7K | 0.01% |
| Occudo Quantitative Strategies LP | 13,117 | $95.2K | 0.01% |
| Squarepoint Ops LLC | 12,076 | $87.7K | 0.00% |
| Tower Research Capital LLC (TRC) | 5,728 | $41.6K | 0.00% |
| Simplex Trading, LLC | 4,578 | $33.0K | 0.00% |
| Steward Partners Investment Advisory, LLC | 3,500 | $25.4K | 0.00% |
| IFP Advisors, Inc | 834 | $2.88K | 0.00% |
| Sunbelt Securities, Inc. | 294 | $2.13K | 0.00% |
| Barclays PLC | 148 | $1.07K | 0.00% |
| Spire Wealth Management | 80 | $581 | 0.00% |
Sold out (5)
Institutions that held ProPhase Labs, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Acadian Asset Management LLC | 97,184 | $739.0K |
| Navellier & Associates Inc | 58,566 | $446.3K |
| UBS Group AG | 4,748 | $36.2K |
| Advisory Services Network, LLC | 790 | $6.02K |
| GWM Advisors LLC | 225 | $1.71K |